Last reviewed · How we verify
NCT07088575
Practice of Deep Venous Thrombosis Prophylaxis and Its Incidence in Patients Undergoing Gastrointestinal and Hepatobiliary Surgery
trial testing major gastrointestinal or hepatobiliary surgery under general anesthesia in Gastrointestinal in 1,530 participants. Completed in 24 July 2024.
21 July 2024
Quick facts
| Lead sponsor | Maharajgunj Medical Campus |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,530 |
| Start date | 23 May 2024 |
| Primary completion | 21 July 2024 |
| Estimated completion | 24 July 2024 |
| Sites | 1 location across Nepal |
Drugs / interventions tested
- major gastrointestinal or hepatobiliary surgery under general anesthesia
Conditions studied
- Gastrointestinal — all drugs for Gastrointestinal →
Sponsor
Maharajgunj Medical Campus — full company profile →
Who can join
18 and older, any sex, with Gastrointestinal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Recent studies from Asia have reported a wide variation in the incidence of deep vein thrombosis (DVT), ranging from 5% to 50% in patients undergoing major abdominal surgery. However, data specific to the Nepalese population remains unavailable. This study aims to evaluate current thromboprophylaxis practices and determine the incidence of DVT in Nepalese adults undergoing gastrointestinal and hepatobiliary surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07088575
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastrointestinal
Currently open trials in the same condition.
- NCT07423897 — Consumer Health Study Aims to Evaluate the Safety, Tolerability and Impact of ED02 Probiotic Supplement on Gastrointesti · NA · active not recruiting
- NCT07356583 — Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on · recruiting
Other Maharajgunj Medical Campus trials
Trials by the same sponsor.
- NCT07026721 — Comparative Analysis of RIRS Scoring System and Resorlu Unsal Stone Score (RUSS) for Predicting Stone-free Rate After Re · completed
- NCT06746207 — Evaluating Patient and Caregiver Satisfaction with the Informed Consent Process in Surgery · completed
- NCT07130422 — Incidence and Risk Factors of Surgical Site Infections After Coronary Artery Bypass Grafting Surgery · completed
- NCT06729931 — Quantitative C-Reactive Protein for Differentiating Tuberculous and Malignant Pleural Effusion: a Cross-Sectional Study · completed
- NCT07050199 — Risk Factors Affecting Mortality in Perforated Peptic Ulcer · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07088575 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Maharajgunj Medical Campus
- Last refreshed: 28 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07088575.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing